Serina Therapeutics Inc. (SER)
NYSE: SER
· Real-Time Price · USD
5.28
-0.22 (-4.00%)
At close: Aug 15, 2025, 3:59 PM
5.20
-1.52%
After-hours: Aug 15, 2025, 07:49 PM EDT
Serina Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.04M | 4.27M | 3.67M | 3.19M | 6.06M | 8.71M | 345K | 397K | 8.72M | 280K | 645K | 466K | 702K | 448K | 584K | 731K | 615K | 809K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 50K | 50K | 50K | 10.6M | 10.43M | 10.25M | 10.08M | 50K | 50K | 50K | 50K | 50K | n/a | 50K | n/a |
Other Long-Term Assets | n/a | n/a | n/a | 333K | n/a | 50K | -1.35M | n/a | -10.25M | 705K | 428.53K | 771K | 804K | 837K | 870K | 952K | 935K | 50K |
Receivables | n/a | n/a | n/a | 14K | 51K | 65K | 57K | 71K | n/a | 6K | n/a | 1K | 12K | n/a | 25K | 24K | 11K | 48K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.95M | 150K | 77K | 143K | 2K | 166K | 352K | 673K | n/a | 1.46M | n/a | 720K | 1.01M | 1.38M | 1.63M | 720K | 930K | 1.28M |
Total Current Assets | 7.99M | 5.75M | 5.68M | 5.42M | 8.92M | 8.94M | 754K | 1.14M | 8.74M | 1.75M | 2.45M | 1.19M | 1.73M | 1.83M | 2.23M | 1.48M | 1.56M | 2.14M |
Property-Plant & Equipment | 950K | 977K | 1.05M | 1.12M | 1.2M | 1.29M | 1.35M | n/a | 1M | n/a | 309.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | 509K | 541K | 574K | 607K | 640K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 968K |
Total Long-Term Assets | 950K | 977K | 1.05M | 2.01M | 1.79M | 1.92M | 11.21M | 11.07M | 1M | 10.78M | 788K | 821K | 854K | 887K | 920K | 952K | 985K | 1.02M |
Total Assets | 8.94M | 6.73M | 6.72M | 7.43M | 10.71M | 10.86M | 11.96M | 12.21M | 9.74M | 12.53M | 3.24M | 2.01M | 2.58M | 2.72M | 3.15M | 2.43M | 2.54M | 3.16M |
Account Payables | 1.71M | 1.19M | 744K | 1.7M | 1.2M | 2.6M | 580K | 1.17M | 360.25K | 707K | 143.34K | 351K | 161K | 501K | 193K | 184K | 483K | 370K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 116.5K | n/a | 153.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 10.46M | 10.66M | 9.98M | 3.67M | 1.53M | 7.61M | 20.04M | 7.65M | 7.3M | 6.97M | 6.66M | 7.14M | 5.6M | 3.56M | 2.02M |
Other Current Liabilities | 3.56M | 595K | 1.06M | 1M | 114K | -51K | 1.08M | 506K | n/a | 1.78M | 3.99M | 1.16M | 1.96M | 2.94M | 1.63M | 814K | 1.23M | 1.33M |
Total Current Liabilities | 3.56M | 2.35M | 2.37M | 13.51M | 12.63M | 14.06M | 5.91M | 3.2M | 8.58M | 22.52M | 10.08M | 8.81M | 9.09M | 10.1M | 8.97M | 6.6M | 5.27M | 3.93M |
Long-Term Debt | 185K | n/a | n/a | 693K | 693K | 693K | 693K | 693K | n/a | 10.01M | 1.62M | 8.35M | 6.76M | 4.21M | 6.06M | 5.81M | 5.56M | 5.33M |
Other Long-Term Liabilities | 3.55M | 2.59M | 3.58M | 6.74M | 13.41M | n/a | n/a | n/a | 36.05M | n/a | 8.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 3.73M | 2.82M | 3.85M | 7.75M | 14.47M | 1.11M | 693K | 693K | 36.44M | 10.01M | 10.48M | 8.35M | 6.76M | 4.21M | 6.06M | 5.81M | 5.56M | 5.33M |
Total Liabilities | 7.29M | 5.17M | 6.22M | 21.26M | 27.1M | 15.16M | 6.61M | 3.9M | 45.03M | 32.54M | 20.56M | 17.16M | 15.84M | 14.31M | 15.03M | 12.4M | 10.84M | 9.26M |
Total Debt | 185K | 227K | 268K | 11.47M | 11.71M | 11.08M | 4.37M | 2.22M | 8.19M | 30.05M | 18.12M | 15.65M | 13.72M | 10.87M | 13.2M | 11.41M | 9.12M | 7.35M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | n/a | 4K | 22.34K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -55.58M | -49.13M | -44.32M | -21.77M | -23.18M | -5.43M | -33.18M | -127.56M | -35.98M | -119.49M | -116.21M | -113.51M | -111.07M | -108.45M | -105.75M | -103.59M | -101.64M | -99.16M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 1.8M | 1.7M | 641K | -13.77M | -16.36M | -4.31M | 4.11M | 8.42M | -35.29M | -19.89M | -17.21M | -15.1M | -13.22M | -11.55M | -11.83M | -9.94M | -8.25M | -6.06M |
Total Investments | n/a | n/a | n/a | 50K | 50K | 50K | 10.6M | 10.43M | 10.25M | 10.08M | 50K | 50K | 50K | 50K | 50K | n/a | 50K | n/a |